Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of TNXP: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4745−2
Shares5.59M9.32M+3.73M (+66.7%)
Value$2.99M$3.63M+$642.4K (+21.5%)

New holders (11)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to TNXP in Q4 2022
InstitutionSharesValue% of portfolio
Tang Capital Management LLC4,500,419$1.75M0.25%
Acadian Asset Management LLC899,514$349.0K0.00%
Raymond James & Associates168,006$65.5K0.00%
Two Sigma Securities, LLC55,484$21.6K0.00%
Commonwealth Equity Services, LLC38,159$14.0K0.00%
StoneX Group Inc.12,728$4.96K0.00%
Condor Capital Management10,000$3.90K0.00%
Allworth Financial LP1,000$3900.00%
Global Wealth Strategies & Associates17$70.00%
FMR LLC1$00.00%
CoreCap Advisors, LLC1$00.00%

Sold out (13)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q3 2022 and filed for Q4 2022 without it.